Surgery Partners, Inc. (NASDAQ:SGRY) Shares Sold by Point72 Asset Management L.P.

Point72 Asset Management L.P. trimmed its position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 56.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 537,915 shares of the company's stock after selling 693,209 shares during the period. Point72 Asset Management L.P. owned about 0.42% of Surgery Partners worth $17,342,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. KBC Group NV lifted its stake in shares of Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company's stock valued at $77,000 after buying an additional 576 shares during the period. DekaBank Deutsche Girozentrale raised its holdings in Surgery Partners by 102.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company's stock valued at $80,000 after acquiring an additional 1,375 shares during the last quarter. Quarry LP lifted its stake in shares of Surgery Partners by 133.1% during the 2nd quarter. Quarry LP now owns 3,082 shares of the company's stock worth $73,000 after purchasing an additional 1,760 shares during the period. Point72 Asia Singapore Pte. Ltd. boosted its holdings in shares of Surgery Partners by 747.6% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company's stock worth $124,000 after purchasing an additional 3,379 shares during the last quarter. Finally, Creative Planning purchased a new stake in shares of Surgery Partners in the third quarter valued at $258,000.

Analyst Upgrades and Downgrades

SGRY has been the topic of several recent analyst reports. Macquarie reiterated an "outperform" rating and set a $34.00 target price on shares of Surgery Partners in a research report on Tuesday, November 19th. JPMorgan Chase & Co. decreased their target price on shares of Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a research report on Tuesday. KeyCorp began coverage on shares of Surgery Partners in a research report on Friday, October 11th. They set a "sector weight" rating for the company. Benchmark reiterated a "buy" rating and issued a $50.00 price target on shares of Surgery Partners in a report on Monday, August 26th. Finally, UBS Group started coverage on Surgery Partners in a report on Monday, October 14th. They set a "buy" rating and a $38.00 price objective for the company. One analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $37.38.

Surgery Partners Stock Up 2.0 %

Surgery Partners stock traded up $0.43 during trading on Friday, reaching $21.89. 1,373,440 shares of the company's stock were exchanged, compared to its average volume of 1,453,903. Surgery Partners, Inc. has a 52-week low of $21.10 and a 52-week high of $36.92. The firm has a market cap of $2.78 billion, a price-to-earnings ratio of -45.60, a PEG ratio of 18.75 and a beta of 2.58. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The company's 50-day moving average is $28.00 and its two-hundred day moving average is $28.10.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.06). The company had revenue of $770.40 million during the quarter, compared to analysts' expectations of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. Surgery Partners's quarterly revenue was up 14.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.15 EPS. On average, analysts predict that Surgery Partners, Inc. will post 0.73 earnings per share for the current year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.